Fibrinogen and neutrophil-to-lymphocyte ratio predicts survival in patients with advanced hypopharyngeal squamous cell Carcinoma

Tatsu Kuwahara, Hideaki Takahashi, Daisuke Sano, Mitsuteru Matsuoka, Hiroshi Hyakusoku, Takashi Hatano, Yohei Hiiragi, Nobuhiko Oridate

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Abstract

Background/Aim: The purpose of this study is to investigate the prognostic significance of the pretreatment F-NLR score, which is based on fibrinogen (F) and neutrophil-to-lymphocyte ratio (NLR) in patients with advanced hypopharyngeal carcinoma (HPC). Materials and Methods: A total of 111 advanced HPC patients treated with radiotherapy, chemoradiotherapy, or bioradiotherapy were classified into three groups: F-NLR score of 2 (fibrinogen ≥341 mg/dl and NLR≥3.59), score of 1 (fibrinogen ≥341 mg/dl or NLR≥3.59), and score of 0 (fibrinogen <341 mg/dl and NLR<3.59). Results: F-NLR score of 2 was an independent prognostic factor for overall (OS) and progression-free survival (PFS) in patients with advanced HPC in the multivariate analysis. Both OS and PFS were significantly lower in patients with an F-NLR score of 2 than in those with an F-NLR score of 0. Conclusion: F-NLR score was useful to stratify patients to extract poor prognostic characteristics in patients with advanced HPC.

Original languageEnglish (US)
Pages (from-to)5321-5330
Number of pages10
JournalAnticancer research
Volume38
Issue number9
DOIs
StatePublished - Sep 2018

Keywords

  • F-NLR score
  • Hypopharyngeal squamous cell carcinoma
  • Neutrophil-to-lymphocyte ratio
  • Pretreatment biomarker
  • Radiotherapy

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Fibrinogen and neutrophil-to-lymphocyte ratio predicts survival in patients with advanced hypopharyngeal squamous cell Carcinoma'. Together they form a unique fingerprint.

Cite this